Αποτελέσματα Αναζήτησης
7 Νοε 2002 · It has been suggested that vaccination against measles, mumps, and rubella (MMR) is a cause of autism. We conducted a retrospective cohort study of all children born in Denmark from January...
- Measles Encephalomyelitis
Acute measles encephalomyelitis is distinct from two rare...
- Immune Activation in Measles
Measles encephalomyelitis: lack of evidence of viral...
- Measles Encephalomyelitis
This retrospective cohort study aims to evaluate the impact of MMR vaccination on hospitalization for infectious events and respiratory pathologies (including asthma), and focuses on the pediatric population in the areas of competence of the local health unit ASL Rome1, for a follow up of 2 y.
20 Σεπ 2019 · Background. Measles is an important cause of death in children, despite the availability of safe and cost-saving measles-containing vaccines (MCVs). The first MCV dose (MCV1) is recommended at 9 months of age in countries with ongoing measles transmission, and at 12 months in countries with low risk of measles.
1 Σεπ 2020 · Our meta-analysis provides estimates of primary and secondary vaccine failure, which are essential to improve the accuracy of mathematical and statistical modelling to understand and predict the occurrence of future measles, mumps, and rubella outbreaks in countries with high vaccine uptake.
8 Φεβ 2022 · A phase II, randomized, observer blind, controlled, multicenter study to assess immunogenicity and antibody persistence following vaccination with GSK’s candidate combined measles, mumps, and rubella vaccine (MMR) versus M-M-R® II as a first dose, both administered subcutaneously at 12-15 months of age, concomitantly with hepatitis a vaccine ...
10 Δεκ 2020 · Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial. Trials. 2020 Dec 10;21 (1):1015. doi: 10.1186/s13063-020-04845-7.
Measles, mumps, and rubella are highly contagious diseases associated with significant medical and societal burden. Effective vaccines against these diseases are available, and the implementation of vaccination programs drastically reduced disease incidence globally.
